SCHEMBL7145528

SCHEMBL7145528

CC(C)(C)OC(=O)CCNC(=O)c1cccc(N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 1/20 0.48
CTSG P08311 1/20 0.48
CTRB1 P17538 1/20 0.48
CMA1 P23946 1/20 0.48
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
PTPRC P08575 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
DGAT2 Q96PD7 1/20 0.43
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TP53BP1 Q12888 2/20 0.42
POLB P06746 1/20 0.42
PTGS1 P23219 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900184 0.86 PRSS1 (0.53) PRSS1CTSGCTRB1CMA1ALDH1A1
SCHEMBL10123873 0.85 ALDH1A1 (0.47) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL22702327 0.83 ESRRG (0.55) PRSS1CTSGCTRB1CMA1ALDH1A1
SCHEMBL27453159 0.83 PRSS1 (0.69) PRSS1CTSGCTRB1CMA1KDM4E
SCHEMBL12325609 0.83 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL14441169 0.82 TP53BP1 (0.62) PRSS1CTSGCTRB1CMA1PTPRC
SCHEMBL10630944 0.80 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2L3MBTL1POLB
SCHEMBL8866585 0.80 SMYD3 (0.46) PRSS1CTSGCTRB1CMA1KDM4E
SCHEMBL277398 0.79 KDM4E (0.50) PRSS1CTSGCTRB1CMA1ALDH1A1
SCHEMBL27371604 0.79 ITGB3 (0.54) PRSS1CTSGCTRB1CMA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 PRSS1 1874/4885CTSG 3533/4885CTRB1 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.